Following the market opening Wednesday, the Dow traded up 0.99% to 34,824.47 while the NASDAQ climbed 1.40% to 15,755.57. The S&P also rose, gaining 1.39% to 4,630.57.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 49,428,910 cases with around 803,040 deaths. India confirmed a total of at least 34,596,770 cases and 469,240 deaths, while Brazil reported over 22,094,450 COVID-19 cases with 614,750 deaths. In total, there were at least 263,226,130 cases of COVID-19 worldwide with more than 5,236,980 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Energy shares climbed 2.2% on Wednesday. Meanwhile, top gainers in the sector included Vertex Energy, Inc. VTNR, up 14% and Transportadora de Gas del Sur S.A. TGS up 10%.
In trading on Wednesday, health care shares rose by just 0.4%.
Top Headline
G-III Apparel Group, Ltd. GIII reported better-than-expected results for its third quarter on Wednesday.
G-III Apparel Group reported quarterly earnings of $2.16 per share, beating analysts’ estimates of $1.78 per share. The company’s quarterly sales came in at $1.02 billion, versus expectations of 1.01 billion.
G-III said it sees FY22 EPS of $3.65-$3.75 and sales of $2.77 billion.
Equities Trading UP
OceanPal Inc. OP shares shot up 75% to $9.14 after completion of spinoff from Diana Shipping on Tuesday.
Shares of Arbutus Biopharma Corporation ABUS got a boost, shooting 35% to $4.33. Moderna lost appeals of Board's rulings on Arbutus Patents, Bloomberg reported.
Ambarella, Inc. AMBA shares were also up, gaining 25% to $224.85 after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
Check out these big movers of the day
Equities Trading DOWN
BeyondSpring Inc. BYSI shares tumbled 55% to $5.80 after the company announced the FDA issued a Complete Response Letter related to the company's plinabulin New Drug Application. HC Wainwright & Co. downgraded BeyondSpring from Buy to Neutral.
Shares of Cumberland Pharmaceuticals Inc. CPIX were down 19% to $4.08. Cumberland Pharmaceuticals shares jumped 128% on Tuesday after the company announced the FDA approved expanded labeling for Caldolor to now include use in pre-operative administration.
CTI BioPharma Corp. CTIC was down, falling 18% to $1.8499 after the company said the FDA has extended the review period for the new drug application for pacritinib for the treatment of adult patients with intermediate or high-risk primary or secondary myelofibrosis with a baseline platelet count of less than 50 × 109/L.
Commodities
In commodity news, oil traded up 4.3% to $69.01, while gold traded up 0.6% to $1,787.40.
Silver traded up 0.4% Wednesday to $22.82 while copper rose 1% to $4.3245.
Euro zone
European shares were higher today. The eurozone’s STOXX 600 gained 1%, the Spanish Ibex Index gained 1.4% and the German DAX 30 climbed 1.5%. Meanwhile, the London’s FTSE 100 rose 1.3%, French CAC 40 climbed 1.3% and Italy’s FTSE MIB jumped 1.6%.
Italy’s manufacturing PMI climbed to an all-time high of 62.8 in November. Germany’s manufacturing PMI fell to 57.4 in November from a preliminary reading of 57.6, while retail trade fell 0.3% in October. The IHS Markit Spain manufacturing PMI fell to 57.1 in November from 57.4 in the prior month. Annual house price growth in the UK rose to 10.0% in November from 9.9% in the earlier month.
Economics
Private businesses hired 534,000 workers in November, versus a revised 570,000 rise in the previous month.
The IHS Markit manufacturing PMI slipped to 58.3 in November from a preliminary reading of 59.1.
The ISM manufacturing composite index climbed to 61.1 in November from previous reading of 60.8.
US construction spending rose 0.2% for October.
The Energy Information Administration’s weekly report on petroleum inventories in the U.S. is scheduled for release at 10:30 a.m. ET.
The Federal Open Market Committee will release its latest Beige Book report at 2:00 p.m. ET.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
